BioCentury
ARTICLE | Company News

GSK divests Affymax business

July 30, 2001 7:00 AM UTC

GlaxoSmithKline (GSK) will sell its Affymax (Palo Alto, Calif.) business to a venture syndicate led by Patricof & Co. Ventures. In exchange, GSK will receive non-voting preferred shares in the new com...